Dr. Ali Adel Dawood
My Social Links

Dr. Ali Adel Dawood

Assistant Professor
College of Medicine, University of Mosul, Iraq

Highest Degree
Ph.D. in Microbiology from University of Mosul, Mosul, Iraq

Share this Profile

Biography

Currently, I am working on various studies of the Corona virus in terms of finding mutations and searching for a vaccine for mutations that occur in the virus. I use various bioinformatics techniques according to the mutagenic chains of the virus.

Area of Interest:

Microbiology
100%
Gel Electrophoresis
62%
DNA and Plasmid Extraction
90%
Genetic Engineering
75%
Molecular Biotechnology
55%

Research Publications in Numbers

Books
1
Chapters
0
Articles
42
Abstracts
0

Selected Publications

  1. Dawood, A.A., 2023. The efficacy of Paxlovid against COVID-19 is the result of the tight molecular docking between Mpro and antiviral drugs (nirmatrelvir and ritonavir). Adv. Med. Sci., 68: 1-9.
    CrossRef  |  Direct Link  |  
  2. Dawood, A.A., B.I. Jasim and O.R. Al-Jalily, 2022. Identification of Surface Glycoprotein Mutations of SARS-CoV-2 in Isolated Strains from Iraq. Med. immunol., 24: 729-740.
    CrossRef  |  Direct Link  |  
  3. Dawood, A.A., Al-Rrassam, A.Z. Thanoon and M. Abduljabar, 2022. Did the SARS-CoV-2 come from wild, mutagenic or artificial type? Complete genome analysis. Res. J. Sci. Technol., 14: 21-29.
    Direct Link  |  
  4. Dawood, A.A., 2022. Influence of SARS-CoV-2 variants spike glycoprotein and RNA-dependent RNA polymerase (nsp12) mutations on remdesivir docking residues. Med. immunol., 24: 617-628.
    CrossRef  |  Direct Link  |  
  5. Dawood, A.A., 2022. Increasing the frequency of omicron variant mutations boosts the immune response and may reduce the virus virulence. Micro. Pathogen., Vol. 164. 10.1016/j.micpath.2022.105400.
    CrossRef  |  Direct Link  |  
  6. Dawood, A.A., 2022. Implementation of immuno-chemoinformatics approaches to construct multi-epitope for vaccine development against Omicron and Delta SARS-CoV-2 variants [Spanish]. Vacunas, 23: S18-S31.
    CrossRef  |  Direct Link  |  
  7. Dawood, A.A., 2022. Hepatitis B Virus, Genotypes and Subtypes. In: Hepatitis B. Rodrigo, L., (Eds)., IntechOpen U.K. pp: 1.
    CrossRef  |  Direct Link  |  
  8. Dawood, A.A., 2022. Enhancement of antibodies neutralize omicron variants in the presence of booster vaccine doses and monoclonal antibodies. Res. J. Sci. Technol., 14: 95-97.
    CrossRef  |  Direct Link  |  
  9. Altai, H., M. Altobje and A. Dawood, 2022. The effect of ganoderma lucidum powder on some immune parameters in rat. Rafidain J. Sci., 31: 1-10.
    CrossRef  |  Direct Link  |  
  10. Dawood, A.A., M.A.A. Altobje and Z.T. Alrassam, 2021. Elevation of BSF-2 level in serum of patients with hepatitis B virus. Med. immunol., 23: 87-94.
    CrossRef  |  Direct Link  |  
  11. Dawood, A.A., M.A.A. Altobje and Z.T. Al-Rrassam, 2021. Molecular docking of sars-cov-2 nucleocapsid protein with angiotensin-converting enzyme II. Mikrobiol. Z., 83: 82-92.
    CrossRef  |  Direct Link  |  
  12. Dawood, A.A., M.A. Altobje and H. Abdul-Malik Alnori, 2021. Compatibility of the ligand binding sites in the spike glycoprotein of covid-19 with those in the aminopeptidase and the caveolins 1, 2 proteins. Res. J. Pharm. Technol., 14: 4760-4766.
    CrossRef  |  Direct Link  |  
  13. Dawood, A.A., 2021. What do you know about the second wave of covid-19? Res. J. Sci. Technol., 11: 218-220.
    CrossRef  |  Direct Link  |  
  14. Dawood, A.A., 2021. Using remdesivir and dexamethasone for treatment of sars-cov-2 shortens the patients stay in the hospital. Asian J. Pharmaceut. Res., 11: 138-140.
    CrossRef  |  Direct Link  |  
  15. Dawood, A.A., 2021. Transmission of SARS CoV-2 virus through the ocular mucosa worth taking precautions [Spanish]. Vacunas, 22: 56-57.
    CrossRef  |  Direct Link  |  
  16. Dawood, A.A., 2021. The russian vaccine of covid-19 (sputnik v) has shown side effects on the volunteers. Asian J. Res. Pharmaceut. Sci., 11: 193-194.
    CrossRef  |  Direct Link  |  
  17. Dawood, A.A., 2021. The effects of the russian vaccine (Sputnik V) on the volunteers. Apollo Med., 18: 52-53.
    CrossRef  |  Direct Link  |  
  18. Dawood, A.A., 2021. Reasons for discontinuing the use of hydroxychloroquine in the treatment of the novel coronavirus. Asian J. Pharmaceut. Ana., 11: 179-180.
    CrossRef  |  Direct Link  |  
  19. Dawood, A.A., 2021. Identification of cytotoxic t-cell and b-cell epitopes in the nucleocapsid phosphoprotein of SARS-cov-2 using immunoinformatics. Mikrobiol. Z., 83: 78-86.
    CrossRef  |  Direct Link  |  
  20. Dawood, A.A., 2021. Glycosylation, ligand binding sites and antigenic variations between membrane glycoprotein of COVID-19 and related coronaviruses. Vacunas, 22: 1-9.
    CrossRef  |  Direct Link  |  
  21. Dawood, A.A., 2021. COVID-19: What are the precautionary measures that you do if you travel to a country with the epidemic? Vet. Med. Public Health J., 2: 23-24.
    CrossRef  |  Direct Link  |  
  22. Dawood, A.A. and M.A. Altobje, 2020. Inhibition of N-linked glycosylation by tunicamycin may contribute to the treatment of SARS-CoV-2. Microb. Pathogen., Vol. 149. 10.1016/j.micpath.2020.104586.
    CrossRef  |  Direct Link  |  
  23. Dawood, A. and H. Abdul-Malik Alnori, 2020. Tunicamycin anticancer drug may reliable to treat coronavirus disease-19. Open Access Maced. J. Med. Sci., 8: 129-133.
    CrossRef  |  Direct Link  |  
  24. Dawood, A., 2019. Different vectors used to transform and clone of nonstructural NS1 gene of Influenza B in Escherichia coli. Iraqi J. Vet. Sci., 33: 329-333.
    CrossRef  |  Direct Link  |